Search

everythinglearnresearchcommunity

for

Search:↓

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

COVID-19 reinfection may trigger alopecia areata.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Some children may develop hair loss after having COVID-19.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Healthy lifestyle changes can significantly improve skin health as you age.

Scientists made nanoparticles from human hair proteins to improve drug delivery.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Early diagnosis and treatment of systemic-onset juvenile idiopathic arthritis are crucial for improvement.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Long-COVID has diverse, long-term health impacts, especially in young people.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Zinc deficiency in children can cause skin issues and can be serious if not diagnosed and treated properly.

The Rotterdam Study aims to understand various diseases in older adults.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Humans and pets share similar allergy mechanisms, and studying pet allergies can help treat both human and animal allergies.

Ginkgo biloba leaf polysaccharides have many health benefits and potential for commercial use.